Home
/
HEALTHEQUITY, INC.
/
Financials
/
Quarterly
HEALTHEQUITY, INC. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that HEALTHEQUITY, INC. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q1
2019
Apr 30, 2018
$69.90M
Jun 7, 2018
Q3
2018
Oct 31, 2017
$56.79M
Dec 7, 2017
Q2
2018
Jul 31, 2017
$56.88M
Sep 7, 2017
Q1
2019
Apr 30, 2017
$55.42M
Jun 7, 2018
Q3
2018
Oct 31, 2016
$43.36M
Dec 7, 2017
Q2
2018
Jul 31, 2016
$44.19M
Sep 7, 2017
Q1
2018
Apr 30, 2016
$44.01M
Jun 8, 2017
Q3
2017
Oct 31, 2015
$30.56M
Dec 8, 2016
Q2
2017
Jul 31, 2015
$30.49M
Sep 8, 2016
Q1
2017
Apr 30, 2015
$29.85M
Jun 9, 2016
Q3
2016
Oct 31, 2014
$21.86M
Dec 9, 2015
Q2
2016
Jul 31, 2014
$20.89M
Sep 10, 2015
Q1
2016
Apr 30, 2014
$20.23M
Jun 11, 2015
Q3
2015
Oct 31, 2013
$15.25M
Dec 11, 2014
Q2
2015
Jul 31, 2013
$14.98M
Sep 12, 2014
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2026
Oct 31, 2025
$322.16M
Dec 3, 2025
Q2
2026
Jul 31, 2025
$325.84M
Sep 2, 2025
Q1
2026
Apr 30, 2025
$330.84M
Jun 3, 2025
Q3
2026
Oct 31, 2024
$300.43M
Dec 3, 2025
Q2
2026
Jul 31, 2024
$299.93M
Sep 2, 2025
Q1
2026
Apr 30, 2024
$287.60M
Jun 3, 2025
Q3
2025
Oct 31, 2023
$249.22M
Dec 9, 2024
Q2
2025
Jul 31, 2023
$243.55M
Sep 3, 2024
Q1
2025
Apr 30, 2023
$244.43M
Jun 3, 2024
Q3
2024
Oct 31, 2022
$216.09M
Dec 5, 2023
Q2
2024
Jul 31, 2022
$206.14M
Sep 5, 2023
Q1
2024
Apr 30, 2022
$205.68M
Jun 7, 2023
Q3
2023
Oct 31, 2021
$179.95M
Dec 8, 2022
Q2
2023
Jul 31, 2021
$189.10M
Sep 8, 2022
Q1
2023
Apr 30, 2021
$184.20M
Jun 8, 2022
Q3
2022
Oct 31, 2020
$179.35M
Dec 9, 2021
Q2
2022
Jul 31, 2020
$176.04M
Sep 9, 2021
Q1
2022
Apr 30, 2020
$190.01M
Jun 8, 2021
Q3
2021
Oct 31, 2019
$157.12M
Dec 9, 2020
Q2
2021
Jul 31, 2019
$86.62M
Sep 9, 2020
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2026
Oct 31, 2025
$51.69M
Dec 3, 2025
Q2
2026
Jul 31, 2025
$59.85M
Sep 2, 2025
Q1
2026
Apr 30, 2025
$53.92M
Jun 3, 2025
Q3
2026
Oct 31, 2024
$5.70M
Dec 3, 2025
Q2
2026
Jul 31, 2024
$35.82M
Sep 2, 2025
Q1
2026
Apr 30, 2024
$28.81M
Jun 3, 2025
Q3
2025
Oct 31, 2023
$14.67M
Dec 9, 2024
Q2
2025
Jul 31, 2023
$10.58M
Sep 3, 2024
Q1
2025
Apr 30, 2023
$4.09M
Jun 3, 2024
Q3
2024
Oct 31, 2022
($1.64M)
Dec 5, 2023
Q2
2024
Jul 31, 2022
($10.65M)
Sep 5, 2023
Q1
2024
Apr 30, 2022
($13.64M)
Jun 7, 2023
Q3
2023
Oct 31, 2021
($5.04M)
Dec 8, 2022
Q2
2023
Jul 31, 2021
($3.82M)
Sep 8, 2022
Q1
2023
Apr 30, 2021
($2.62M)
Jun 8, 2022
Q3
2022
Oct 31, 2020
$1.79M
Dec 9, 2021
Q2
2022
Jul 31, 2020
($148.0K)
Sep 9, 2021
Q1
2022
Apr 30, 2020
$1.83M
Jun 8, 2021
Q3
2021
Oct 31, 2019
($21.33M)
Dec 9, 2020
Q2
2021
Jul 31, 2019
$19.37M
Sep 9, 2020
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2026
Oct 31, 2025
$78.70M
Dec 3, 2025
Q2
2026
Jul 31, 2025
$89.61M
Sep 2, 2025
Q1
2026
Apr 30, 2025
$83.08M
Jun 3, 2025
Q3
2026
Oct 31, 2024
$19.63M
Dec 3, 2025
Q2
2026
Jul 31, 2024
$58.93M
Sep 2, 2025
Q1
2026
Apr 30, 2024
$41.63M
Jun 3, 2025
Q3
2025
Oct 31, 2023
$30.89M
Dec 9, 2024
Q2
2025
Jul 31, 2023
$24.74M
Sep 3, 2024
Q1
2025
Apr 30, 2023
$23.18M
Jun 3, 2024
Q3
2024
Oct 31, 2022
$5.54M
Dec 5, 2023
Q2
2024
Jul 31, 2022
($2.41M)
Sep 5, 2023
Q1
2024
Apr 30, 2022
($7.29M)
Jun 7, 2023
Q3
2023
Oct 31, 2021
($366.0K)
Dec 8, 2022
Q2
2023
Jul 31, 2021
($875.0K)
Sep 8, 2022
Q1
2023
Apr 30, 2021
$4.25M
Jun 8, 2022
Q3
2022
Oct 31, 2020
$11.50M
Dec 9, 2021
Q2
2022
Jul 31, 2020
$9.03M
Sep 9, 2021
Q1
2022
Apr 30, 2020
$15.07M
Jun 8, 2021
Q3
2021
Oct 31, 2019
$9.92M
Dec 9, 2020
Q2
2021
Jul 31, 2019
$24.86M
Sep 9, 2020